5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).

• Cardoso F Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
• Paluch-Shimon S Sharett Division of Oncology, Hadassah University Hospital, Jerusalem, Israel.
• Senkus E Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
• Curigliano G Department of Oncology and Hemato-Oncology, European Institute of Oncology, IRCCS, Division of Early Drug Development, University of Milan, Milan, Italy.
• Aapro MS Breast Center, Clinique de Genolier, Genolier, Switzerland.
• André F Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
• Barrios CH Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil.
• Bergh J Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden.
• Bhattacharyya GS Department of Medical Oncology, Salt Lake City Medical Centre, Kolkata, India.
• Biganzoli L Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy.
• Boyle F The Pam McLean Centre, Royal North Shore Hospital, St Leonards, Australia.
• Cardoso MJ Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal; Nova Medical School, Lisbon, Portugal.
• Carey LA Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.
• Cortés J IOB Institute of Oncology, Quiron Group, Madrid & Barcelona, Spain; Department of Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
• El Saghir NS Division of Hematology Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
• Elzayat M Europa Donna, The European Breast Cancer Coalition, Milan, Italy.
• Eniu A Interdisciplinary Oncology Service (SIC), Riviera-Chablais Hospital, Rennaz, Switzerland.
• Fallowfield L SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
• Francis PA Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
• Gelmon K Medical Oncology Department, BC Cancer Agency, Vancouver, Canada.
• Gligorov J Breast Cancer Expert Center, University Cancer Institute APHP, Sorbonne University, Paris, France.
• Haidinger R Brustkrebs Deutschland e.V., Munich, Germany.
• Harbeck N Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany.
• Hu X Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
• Kaufman B Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
• Kaur R Breast Cancer Welfare Association Malaysia, Petaling Jaya, Malaysia.
• Kiely BE NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia.
• Kim SB Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
• Lin NU Susan Smith Center for Women's Cancers - Breast Oncology Center, Dana-Farber Cancer Institute, Boston, USA.
• Mertz SA Metastatic Breast Cancer Network, Inverness, USA.
• Neciosup S Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru.
• Offersen BV Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
• Ohno S Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
• Pagani O Medical School, Geneva University Hospital, Geneva, Switzerland.
• Prat A Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona; Department of Medicine, University of Barcelona, Barcelona.
• Penault-Llorca F Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France; University Clermont Auvergne/INSERM U1240, Clermont-Ferrand, France.
• Rugo HS Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
• Sledge GW Division of Oncology, Stanford School of Medicine, Stanford, USA.
• Thomssen C Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany.
• Vorobiof DA Oncology Research Unit, Belong.Life, Tel Aviv, Israel.
• Wiseman T Department of Applied Health Research in Cancer Care, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
• Xu B Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
• Norton L Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
• Costa A European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
• Winer EP Susan Smith Center for Women's Cancers - Breast Oncology Center, Dana-Farber Cancer Institute, Boston, USA.

ABC

ESO-ESMO

advanced

breast cancer

guidelines

metastatic